Genus Capital Management’s Celestica CLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-61,382
Closed -$5.66M 227
2024
Q4
$5.66M Buy
61,382
+21,068
+52% +$1.65M 0.77% 45
2024
Q3
$2.06M Sell
40,314
-244,904
-86% -$12.7M 0.27% 93
2024
Q2
$16.3M Buy
+285,218
New +$14.4M 2.16% 7
2024
Q1
Sell
-249,226
Closed -$7.34M 241
2023
Q4
$7.34M Buy
+249,226
New +$6.63M 1.08% 27

Other funds holding CLS

Genus Capital Management's CLS Position: Q1 2026 in Review

Genus Capital Management reduced its Celestica (CLS) stake by 25% in Q1 2026, selling an estimated $2.47M and leaving 25,345 shares worth $7.13M. The position accounts for 0.82% of the portfolio, ranked #42.

Genus Capital Management first reported a position in CLS in Q2 2023 and has held it in 8 quarters since. The position peaked at $12.8M in Q1 2024. 774 funds tracked by Wall St. Rank hold CLS as of Q1 2026.

  • Genus Capital Management held 25,345 shares of Celestica worth $7.13M as of Q1 2026.
  • Genus Capital Management sold 8,528 Celestica shares in Q1 2026, an estimated $2.47M.
  • Celestica made up 0.82% of Genus Capital Management's portfolio in Q1 2026, its #42 holding.
  • Genus Capital Management first reported a position in Celestica in Q2 2023 and has held it in 8 quarters since.
  • Genus Capital Management's Celestica position peaked at $12.8M in Q1 2024.
  • 774 funds tracked by Wall St. Rank held Celestica as of Q1 2026.

Based on Genus Capital Management's 13F filing for Q1 2026, filed 4 May 2026.